Darbepoetin alfa
- Generic Name
- Darbepoetin alfa
- Brand Names
- Aranesp
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 209810-58-2
- Unique Ingredient Identifier
- 15UQ94PT4P
- Background
Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.
- Indication
For the treatment of anemia (from renal transplants or certain HIV treatment)
- Associated Conditions
- Anemia
- Associated Therapies
- -
Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia
- First Posted Date
- 2005-12-12
- Last Posted Date
- 2014-05-07
- Lead Sponsor
- Janssen-Cilag B.V.
- Target Recruit Count
- 492
- Registration Number
- NCT00264108
Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies
- First Posted Date
- 2005-10-17
- Last Posted Date
- 2010-03-05
- Lead Sponsor
- Amgen
- Target Recruit Count
- 44
- Registration Number
- NCT00239239
Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
- Conditions
- Interventions
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2009-03-12
- Lead Sponsor
- St. Bartholomew's Hospital
- Target Recruit Count
- 360
- Registration Number
- NCT00234143
- Locations
- 🇬🇧
St Bartholomew's Hospital, London, United Kingdom
A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
- Conditions
- Interventions
- First Posted Date
- 2005-09-30
- Last Posted Date
- 2013-02-04
- Lead Sponsor
- Peter L Greenberg
- Target Recruit Count
- 21
- Registration Number
- NCT00230321
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- The Hospital for Sick Children
- Target Recruit Count
- 40
- Registration Number
- NCT00213291
- Locations
- 🇨🇦
The Hospital for Sick Children, Toronto, Ontario, Canada
Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2009-02-16
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 108
- Registration Number
- NCT00204633
- Locations
- 🇩🇪
Medical Center II, University of Tuebingen, Tuebingen, Germany
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
- Conditions
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Harold J. Burstein, MD, PhD
- Target Recruit Count
- 135
- Registration Number
- NCT00146562
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2015-09-02
- Lead Sponsor
- Lymphoma Study Association
- Target Recruit Count
- 600
- Registration Number
- NCT00144755
- Locations
- 🇨🇭
Schweirische Arbeitsgruppe fur klinische Krebsforschung, Lausanne, Switzerland
🇫🇷Hématologie CHU Purpan, Toulouse, France
🇫🇷Hématologie CHU de Lille, Lille, France
AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies
- Conditions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2013-05-23
- Lead Sponsor
- Amgen
- Registration Number
- NCT00135317
The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery
- Conditions
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2006-07-07
- Lead Sponsor
- Herning Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT00122720
- Locations
- 🇩🇰
Surgical Department, Odense University Hospital, Odense, Fyn, Denmark
🇩🇰Surgical Department, Aarhus University Hospital, Aarhus, Denmark
🇩🇰Surgical Department, Svendborg Hospital, Svendborg, Fyn, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.